Aurinia Pharmaceuticals
AUPH
AUPH
253 hedge funds and large institutions have $1.15B invested in Aurinia Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 87 increasing their positions, 81 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% more funds holding
Funds holding: 240 → 253 (+13)
4.85% more ownership
Funds ownership: 49.91% → 54.76% (+4.8%)
7% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 81
Holders
253
Holding in Top 10
4
Calls
$22M
Puts
$11.4M
Top Buyers
| 1 | +$11.9M | |
| 2 | +$11.7M | |
| 3 | +$9.51M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$9.31M |
| 5 |
Millennium Management
New York
|
+$9.04M |
Top Sellers
| 1 | -$5.22M | |
| 2 | -$4.97M | |
| 3 | -$3.95M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.7M |
| 5 |
LPL Financial
San Diego,
California
|
-$3.67M |
